High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Crossref DOI link: https://doi.org/10.1007/s40120-016-0058-0
Published Online: 2016-12-03
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Malucchi, Simona
Capobianco, Marco
Lo Re, Marianna
Malentacchi, Maria
di Sapio, Alessia
Matta, Manuela
Sperli, Francesca
Bertolotto, Antonio